HomeCompareHGGGQ vs JNJ

HGGGQ vs JNJ: Dividend Comparison 2026

HGGGQ yields 166666.67% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HGGGQ wins by $7.944525992890705e+28M in total portfolio value
10 years
HGGGQ
HGGGQ
● Live price
166666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.944525992890705e+28M
Annual income
$79,351,601,962,005,455,000,000,000,000,000,000.00
Full HGGGQ calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — HGGGQ vs JNJ

📍 HGGGQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHGGGQJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HGGGQ + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HGGGQ pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HGGGQ
Annual income on $10K today (after 15% tax)
$14,166,666.67/yr
After 10yr DRIP, annual income (after tax)
$67,448,861,667,704,640,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, HGGGQ beats the other by $67,448,861,667,704,640,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HGGGQ + JNJ for your $10,000?

HGGGQ: 50%JNJ: 50%
100% JNJ50/50100% HGGGQ
Portfolio after 10yr
$3.972262996445352e+28M
Annual income
$39,675,800,981,002,727,000,000,000,000,000,000.00/yr
Blended yield
99.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HGGGQ
No analyst data
Altman Z
35.7
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HGGGQ buys
0
JNJ buys
0
No recent congressional trades found for HGGGQ or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHGGGQJNJ
Forward yield166666.67%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$7.944525992890705e+28M$30.3K
Annual income after 10y$79,351,601,962,005,455,000,000,000,000,000,000.00$4,689.40
Total dividends collected$7.943912645651793e+28M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HGGGQ vs JNJ ($10,000, DRIP)

YearHGGGQ PortfolioHGGGQ Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$16,677,367$16,666,666.67$10,592$272.30+$16.67MHGGGQ
2$25,995,051,428$25,977,206,645.90$11,289$357.73+$25995.04MHGGGQ
3$37,869,622,473,147$37,841,807,768,118.86$12,123$472.89+$37869622.46MHGGGQ
4$51,562,007,868,526,340$51,521,487,372,480,070.00$13,141$629.86+$51562007868.51MHGGGQ
5$65,615,852,892,511,920,000$65,560,681,544,092,600,000.00$14,408$846.81+$65615852892511.91MHGGGQ
6$78,042,202,741,585,770,000,000$77,971,993,778,990,800,000,000.00$16,021$1,151.60+$78042202741585760.00MHGGGQ
7$86,754,863,367,545,780,000,000,000$86,671,358,210,612,300,000,000,000.00$18,122$1,588.22+$86754863367545782272.00MHGGGQ
8$90,137,108,986,090,100,000,000,000,000$90,044,281,282,286,820,000,000,000,000.00$20,930$2,228.20+$9.01371089860901e+22MHGGGQ
9$87,530,810,188,407,730,000,000,000,000,000$87,434,363,481,792,600,000,000,000,000,000.00$24,792$3,191.91+$8.753081018840772e+25MHGGGQ
10$79,445,259,928,907,045,000,000,000,000,000,000$79,351,601,962,005,455,000,000,000,000,000,000.00$30,274$4,689.40+$7.944525992890705e+28MHGGGQ

HGGGQ vs JNJ: Complete Analysis 2026

HGGGQStock

hhgregg, Inc. operates as an appliance, consumer electronics, and furniture retailer. The company's appliances products include refrigerators, cooking ranges, dishwashers, freezers, washers and dryers, grills, air conditioners, and small home appliances; consumer electronics products comprise LED televisions, audio systems, cameras, and Blu-ray players; furniture, mattresses, and other home products; and computers, computer accessories, and tablets. As of March 2, 2017, it operated 220 stores in 19 states of the United States. The company was founded in 1955 and is headquartered in Carmel, Indiana. On March 6, 2017, hhgregg, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Southern District of Indiana.

Full HGGGQ Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this HGGGQ vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HGGGQ vs SCHDHGGGQ vs JEPIHGGGQ vs OHGGGQ vs KOHGGGQ vs MAINHGGGQ vs ABBVHGGGQ vs MRKHGGGQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.